Organon & Co. (OGN)
9.23
+0.53
(+6.09%)
USD |
NYSE |
Apr 15, 16:00
9.27
+0.04
(+0.43%)
After-Hours: 20:00
Organon Research and Development Expense (Annual) : 366.00M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Merck & Co., Inc. | 12.51B |
| Abbott Laboratories | 2.889B |
| AbbVie, Inc. | 8.249B |
| Replimune Group, Inc. | 191.22M |
| Corcept Therapeutics, Inc. | 254.91M |